Form 8-K - Current report:
SEC Accession No. 0001558370-25-009352
Filing Date
2025-07-22
Accepted
2025-07-22 06:30:21
Documents
13
Period of Report
2025-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20250721x8k.htm   iXBRL 8-K 32854
  Complete submission text file 0001558370-25-009352.txt   157774

Data Files

Seq Description Document Type Size
2 EX-101.SCH pmn-20250721.xsd EX-101.SCH 4155
3 EX-101.DEF pmn-20250721_def.xml EX-101.DEF 2871
4 EX-101.LAB pmn-20250721_lab.xml EX-101.LAB 17906
5 EX-101.PRE pmn-20250721_pre.xml EX-101.PRE 11837
15 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20250721x8k_htm.xml XML 5044
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 251138626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)